City
Epaper

Sputnik V vaccine to be available in market by next week

By Lokmat English Desk | Updated: May 13, 2021 18:11 IST

The second wave of corona has hit the country and more than three lakh corona patients are being registered ...

Open in App

The second wave of corona has hit the country and more than three lakh corona patients are being registered every day. Last week, more than 4 lakh patients were reported in the country.

Despite some improvement in the situation compared to last week, the death toll in the country is increasing day by day. Vaccination needs to be stepped up to prevent coronavirus outbreaks. Therefore, Modi government has approved Sputnik V to be imported from Russia by Dr Reddy's, but is yet to be widely available in India. The sale of the vaccine will begin next week.

The Russian-made Sputnik vaccine will be available in Indian markets next week. Dr. VK Paul, a member of the Niti Aayog, informed about this.

People will be vaccinated with Sputnik vaccine from next week. Sputnik will start production in India from July, Paul said. "I'm happy to say that we're hopeful that it'll be available in the market next week. We're hopeful that the sale of the limited supply that has come from there (Russia), will begin next week," Dr VK Paul said at a press briefing. Further supply will also follow, the senior government official said, adding that Sputnik V will be produced in India from July onwards.

We are constantly working on different levels to make more vaccines available. It is expected that 216 crore doses will be available between August and December.These include 550 million doses of Covaxin, 75 million doses of Covishield, 30 million doses of Bio E sub unit vaccine, 5 crore doses of Zydus Cadilla, 200 million doses of nova vaccine, 100 million doses of Bharat Biotech's nasal vaccine, 6 crore doses of Genoa and it will contain 150 million doses of Sputnik. Apart from this, vaccines from other countries will also come to India, Paul said.

Tags: Sputnik VVk paul committeeNiti AayogCovaxinCovishield
Open in App

Related Stories

TechnologyWill the Government Have to Offer More Incentives on EVs? NITI Aayog Raises Concerns Over Slow Sales Growth

NationalChennai Metro Update: MRTS Handover to CMRL in Final Stage, Awaiting Railway Board and Minister's Nod

NationalNext COVID-19 Like Pandemic Ahead? What NITI Aayog Report Suggests

NationalMaharashtra Govt Forms CS-Led Panel to Develop MMR as $300 Billion Economy by 2030, Focusing on FDI and Startups

MaharashtraBengal CM's 'Insult' At NITI Aayog Doesn't Suit Democratic Norms, Says Sanjay Raut

National Realted Stories

NationalCentre approves mitigation, recovery and reconstruction projects worth Rs 4645.60 crore

NationalRajasthan: Steady decline in crime over last two years, claims police

NationalMaha: Five Dussehra rallies to be held tomorrow; all eyes on Uddhav Thackeray and Eknath Shinde

NationalCentre grants Rs 260.56 crore for rebuilding Wayanad hit by landslide

National‘Deep insult to freedom struggle’: Congress on honouring RSS